Chronic heart failure: contemporary diagnosis and management
Related Experiment Video
Updated: Jun 16, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Gautam V Ramani1, Patricia A Uber, Mandeep R Mehra
1University of Maryland School of Medicine, Baltimore, USA.
Insights
Chronic heart failure (CHF) management focuses on preventing hospitalizations and controlling risk factors like high blood pressure. Advanced treatments include devices and heart transplants for severe cases.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Chronic heart failure (CHF) presents a growing hospitalization burden and healthcare cost.
- Diastolic heart failure is prevalent in the elderly, increasing with age.
- Preventing left ventricular dysfunction requires primary prevention of coronary artery disease and aggressive blood pressure control.
Purpose of the Study:
- To outline optimal management strategies for chronic heart failure.
- To identify patient subgroups benefiting from advanced therapies like implantable cardioverter-defibrillators and cardiac resynchronization therapy.
- To discuss interventions for advanced heart failure stages.
Main Methods:
- Review of current therapeutic approaches for CHF.
- Identification of prognostic indicators for heart failure progression and sudden death.
- Evaluation of criteria for advanced treatment candidacy.
Main Results:
- Aggressive risk factor management, particularly blood pressure control, is key for prevention.
- Etiological phenotype, reduced ejection fraction, and QRS duration identify high-risk patients for device therapy.
- Left ventricular assist devices and cardiac transplantation are options for end-stage disease.
Conclusions:
- Optimal CHF therapy involves addressing reversible causes, optimizing medical treatment, and managing acute decompensations.
- Device therapy (ICD/CRT) is indicated for specific high-risk CHF patients.
- Advanced mechanical support and transplantation are vital for end-stage CHF management.
Abstract:
Chronic heart failure (CHF) remains the only cardiovascular disease with an increasing hospitalization burden and an ongoing drain on health care expenditures. The prevalence of CHF increases with advancing life span, with diastolic heart failure predominating in the elderly population. Primary prevention of coronary artery disease and risk factor management via aggressive blood pressure control are central in preventing new occurrences of left ventricular dysfunction. Optimal therapy for CHF involves identification and correction of potentially reversible precipitants, target-dose titration of medical therapy, and management of hospitalizations for decompensation. The etiological phenotype, absolute decrease in left ventricular ejection fraction and a widening of QRS duration on electrocardiography, is commonly used to identify patients at increased risk of progression of heart failure and sudden death who may benefit from prophylactic implantable cardioverter-defibrillator placement with or without cardiac resynchronization therapy. Patients who transition to advanced stages of disease despite optimal traditional medical and device therapy may be candidates for hemodynamically directed approaches such as a left ventricular assist device; in selected cases, listing for cardiac transplant may be warranted.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies